IXHL

アフターアワーズ： 1.99

Incannex Healthcare Inc (IXHL)

Relative Volume:

ネットキャッシュフロー:

Incannex Healthcare Inc Stock (IXHL) Company Profile

Incannex Healthcare Inc

61 409 840 786

401 DOCKLANDS DRIVE, DOCKLANDS, VICTORIA

IXHL's Discussions on Twitter

Incannex Healthcare Inc (IXHL) 最新ニュース

Incannex Healthcare Inc (IXHL) 財務データ

Incannex Healthcare Inc (IXHL) の財務データはありません。詳細については、他の銘柄を確認してください。

Incannex Healthcare Inc (IXHL)

Incannex Healthcare Inc Stock (IXHL) Company Profile

Incannex Healthcare Inc (IXHL) 最新ニュース

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short Interest - Defense World

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - The Manila Times

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - StockTitan

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat

Incannex Secures Up to $60M in Financing to Support Clinical Trials - Sleep Review

Incannex secures financing deal valued at US$60 million - Mugglehead

Incannex $60 Million Deal With Arena For Late-Stage Drug TrialsIncannex Healthcare (NASDAQ:IXHL) - Benzinga

Incannex Healthcare secures $60 million funding via equity and debt - Investing.com

Incannex Healthcare secures $60 million funding via equity and debt By Investing.com - Investing.com UK

Incannex Healthcare lands $60 million financing deal - Green Market Report

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - GlobeNewswire

Incannex secures $60 million in funding for clinical trials - Investing.com

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - StockTitan

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Large Growth in Short Interest - MarketBeat

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - Defense World

Thinking about buying stock in Altimmune, UiPath, Incannex Healt - GuruFocus.com

Virtu Financial LLC Buys New Shares in Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

4 Psychedelic Stocks to Consider as Clinical Trials Heat up - Investing.com

FDA Review of PsiGAD2 IND complete; clinical trial for - GlobeNewswire

FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety - Benzinga

Incannex Healthcare gets FDA nod for Phase 2 trial - Green Market Report

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed - StockTitan

Tidal Investments LLC Buys New Stake in Incannex Healthcare Inc. (NASDAQ:IXHL) - MarketBeat

Tidal Investments LLC Acquires Shares of 423,410 Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

Dosing completed in 115 participant - GlobeNewswire

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X - Yahoo Finance

Head to Head Review: Zai Lab (NASDAQ:ZLAB) vs. Incannex Healthcare (NASDAQ:IXHL) - Defense World

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 69.0% in June - MarketBeat

7 Best Psychedelic Stocks in 2024 | Investing - U.S News & World Report Money

Patient Dosing Begins in Phase 2/3 Trial for OSA Drug Candidate IHL-42X - Sleep Review

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea - GlobeNewswire Inc.

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea - Yahoo Finance

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder - GlobeNewswire Inc.

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder - Yahoo Finance

'Truly Remarkable’ Results Spur Incannex's Phase 2/3 Trials for Sleep Apnea Drug Candidate, Says CEO - Sleep Review

Incannex prepares IND submission for psychotherapy asset - Pharmaceutical Technology

symbol__ Stock Quote Price and Forecast - CNN

11 Best ASX Stocks To Buy Now - Yahoo Finance

Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado - Quantisnow

Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison ... - Psychedelic Alpha

Incannex’s Psilocybin Clears Phase II Trial in Generalized Anxiety Disorder - BioSpace

Incannex Announces Positive Topline Results from Phase 2 - GlobeNewswire

How to buy Incannex Healthcare (IHL) shares in Australia - finder.com.au

Why Incannex Healthcare's (NASDAQ:IXHL) Earnings Are Weaker Than They Seem - Simply Wall St

Cannabis stocks eye US Federal legalisation after difficult year - Proactive Investors Australia

Incannex advances smoking cessation gum in FDA meeting By Investing.com - Investing.com Australia

Incannex Healthcare targeting $120 billion global addressable market with cannabinoid and psychedelic therapeutics - Proactive Investors Australia

Is Incannex Healthcare (NASDAQ:IXHL) In A Good Position To Invest In Growth? - Simply Wall St

Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne - Mugglehead

Incannex Healthcare Inc Share PriceIXHL, RNS News, Articles, Quotes, & Charts (NASDAQ:IXHL) - Proactive Investors UK

Incannex Healthcare Inc Share PriceIXHL, RNS News, Articles, Quotes, & Charts (NASDAQ:IXHL) - Proactive Investors Australia

Incannex Healthcare Inc (IXHL) 財務データ

収益

当期純利益

現金流量

EPS

IXHLに似た銘柄